Portal Vein Embolisation
Cross-source consensus on Portal Vein Embolisation from 1 sources and 10 claims.
1 sources · 10 claims
How it works
Benefits
Preparation
Risks & contraindications
Comparisons
Highlighted claims
- Portal vein embolisation blocks blood flow to the tumour-containing portion of the liver by injecting embolic material into portal vein branches. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- PVE redirects portal blood flow toward the remaining healthy liver, stimulating compensatory hypertrophy. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- PVEfLR overall survival is significantly lower than liver transplantation in high tumour load patients. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- PVEfLR has higher postoperative complication rates than liver resection without PVE. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- Post-procedure hospital stay is significantly shorter after PVE than after portal vein ligation. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- A notable proportion of patients selected for PVEfLR do not proceed to resection due to inadequate hypertrophy or disease progression, with dropout as high as 28% in one study. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- PVEfLR is an appropriate preoperative strategy for selected patients with initially unresectable CRLM and can produce long-term survival comparable to ALPPS. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- Embolic materials used in PVE include gel foam, ethanol, and polyvinyl-alcohol particles. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- PVEfLR has significantly lower postoperative complication rates than ALPPS. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- Among patients selected for PVE, approximately 80% subsequently undergo liver resection and sufficient liver enlargement is achieved in 96.1% of cases. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review